NuWave Investment Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
NuWave Investment Management's BIIB Position: Q3 2022 in Review
NuWave Investment Management sold out of Biogen (BIIB) in Q3 2022, closing a stake of 4,675 shares — an estimated $953K sold.
NuWave Investment Management first reported a position in BIIB in Q2 2013 and held it in 21 quarters. The position peaked at $1.5M in Q2 2020. 987 funds tracked by Wall St. Rank hold BIIB as of Q3 2022.
- NuWave Investment Management reported no remaining Biogen position as of Q3 2022 after selling out during the quarter.
- NuWave Investment Management sold 4,675 Biogen shares in Q3 2022, an estimated $953K.
- NuWave Investment Management first reported a position in Biogen in Q2 2013 and held it in 21 quarters.
- NuWave Investment Management's Biogen position peaked at $1.5M in Q2 2020.
- 987 funds tracked by Wall St. Rank held Biogen as of Q3 2022.
Based on NuWave Investment Management's 13F filing for Q3 2022, filed 21 Oct 2022.